Swiss SOS MoCA - DCI Study


Phase N/A Results N/A

Summary of Purpose

The primary objective of this multicenter observational study is to determine the effect size of the relationship between DCI and neuropsychological impairment 14-28 days and 3 months after aSAH. Secondary objectives are the feasibility to administer and the validity of the MoCA in an intensive care unit setting, as well as the test/retest reliability of the MoCA in patients with acute brain damage in...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 October 2017.

20 Jul 2017 20 Jan 2017 1 Jul 2019 1 Oct 2019 1 Jul 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available